Teladoc Health, Inc. Expected to Post FY2024 Earnings of ($0.65) Per Share (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC – Get Rating) – SVB Leerink issued their FY2024 earnings per share (EPS) estimates for Teladoc Health in a report released on Wednesday, January 18th. SVB Leerink analyst S. Davis anticipates that the health services provider will earn ($0.65) per share for the year. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.40) per share.

Other research analysts also recently issued reports about the company. Barclays decreased their price objective on Teladoc Health from $32.00 to $28.00 and set an “equal weight” rating for the company in a report on Wednesday. Truist Financial reduced their price target on Teladoc Health from $35.00 to $29.00 and set a “hold” rating for the company in a research report on Friday, October 21st. Citigroup reduced their price target on Teladoc Health from $36.00 to $33.00 and set a “neutral” rating for the company in a research report on Tuesday, December 13th. Credit Suisse Group reduced their price target on Teladoc Health from $35.00 to $30.00 and set a “neutral” rating for the company in a research report on Monday, October 31st. Finally, DA Davidson reduced their price target on Teladoc Health from $45.00 to $40.00 and set a “buy” rating for the company in a research report on Tuesday, October 25th. One equities research analyst has rated the stock with a sell rating, twenty-two have given a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and an average price target of $47.79.

Teladoc Health Stock Up 5.0 %

NYSE:TDOC opened at $26.18 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.99 and a current ratio of 3.13. The company has a market cap of $4.24 billion, a PE ratio of -0.43 and a beta of 0.98. Teladoc Health has a 52-week low of $21.60 and a 52-week high of $80.83. The stock has a 50-day simple moving average of $26.45 and a 200 day simple moving average of $30.30.

Teladoc Health (NYSE:TDOC – Get Rating) last posted its quarterly earnings data on Wednesday, October 26th. The health services provider reported ($0.45) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.14. The business had revenue of $611.40 million during the quarter, compared to the consensus estimate of $609.45 million. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%.

Insider Activity

In other news, insider Arnnon Geshuri sold 2,398 shares of Teladoc Health stock in a transaction on Monday, November 28th. The stock was sold at an average price of $27.35, for a total value of $65,585.30. Following the transaction, the insider now owns 74,317 shares in the company, valued at approximately $2,032,569.95. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, SVP Daniel Trencher sold 1,000 shares of Teladoc Health stock in a transaction on Tuesday, January 17th. The stock was sold at an average price of $26.80, for a total value of $26,800.00. Following the transaction, the senior vice president now owns 21,408 shares in the company, valued at approximately $573,734.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Arnnon Geshuri sold 2,398 shares of the firm’s stock in a transaction on Monday, November 28th. The shares were sold at an average price of $27.35, for a total value of $65,585.30. Following the sale, the insider now directly owns 74,317 shares in the company, valued at approximately $2,032,569.95. The disclosure for this sale can be found here. In the last quarter, insiders have sold 3,925 shares of company stock worth $107,958. Insiders own 1.55% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently modified their holdings of the company. Quadrant Capital Group LLC boosted its holdings in shares of Teladoc Health by 23.3% during the 2nd quarter. Quadrant Capital Group LLC now owns 1,385 shares of the health services provider’s stock valued at $46,000 after acquiring an additional 262 shares in the last quarter. PSI Advisors LLC boosted its holdings in shares of Teladoc Health by 19.3% during the 2nd quarter. PSI Advisors LLC now owns 1,855 shares of the health services provider’s stock valued at $62,000 after acquiring an additional 300 shares in the last quarter. MAI Capital Management boosted its holdings in shares of Teladoc Health by 5.1% during the 2nd quarter. MAI Capital Management now owns 6,928 shares of the health services provider’s stock valued at $230,000 after acquiring an additional 337 shares in the last quarter. Quantum Private Wealth LLC boosted its holdings in shares of Teladoc Health by 3.4% during the 2nd quarter. Quantum Private Wealth LLC now owns 11,614 shares of the health services provider’s stock valued at $385,000 after acquiring an additional 379 shares in the last quarter. Finally, IFP Advisors Inc lifted its holdings in Teladoc Health by 6.4% during the 3rd quarter. IFP Advisors Inc now owns 6,286 shares of the health services provider’s stock worth $349,000 after buying an additional 380 shares during the period. Institutional investors and hedge funds own 84.14% of the company’s stock.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.